Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs-Reference-Cited by-同舟云学术

Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs

Published:2012-01-17 Issue:5 Volume:14 Page:424-432
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Morgan C. Ll.,Jenkins-Jones S.,Evans M.,Barnett A. H.,Poole C. D.,Currie C. J.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2011.01552.x/fullpdf

Reference25 articles.

1. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38).;UK Prospective Diabetes Study Group.;BMJ,1998

2. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy.;Nathan;Diabetes Care,2009

3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).;UK Prospective Diabetes Study Group.;Lancet,1998

4. Secondary failure of metformin monotherapy in clinical practice.;Brown;Diabetes Care,2010

5. Prevalence of overweight and obesity among adults with diagnosed diabetes-United States, 1988-1994 and 1999-2002.;Eberhardt;Morb Mortal Wkly Rep,2004

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population;Diabetologia;2024-07-05

2. The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor;Cardiovascular Diabetology;2021-04-30

3. SGLT 2 Inhibitors; glycemic control, weight loss and safety profile in patients with type 2 Diabetes, at Medicell Institute (MIDEM);Pakistan Journal of Medical Sciences;2020-12-08

4. Scientific independence and objectivity: many questions linger about treatment of type 2 diabetes, such as scientific study design, optimal glucose control and the safety of injecting exogenous insulin;Postgraduate Medicine;2020-07-12

5. Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in East Asians with Type 2 Diabetes: A Systematic Review and Meta-Analysis;Diabetes Therapy;2019-08-02